← Leaderboards
George A. Calin
University Of Tx Md Anderson Can Ctr
$5,774,539
Attributed
$14,502,123
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,502,123 · 8
By mechanism
R01$10,014,346 · 5
UH3$3,158,668 · 1
UH2$1,080,000 · 1
R41$249,109 · 1
Top collaborators
- Gabriel Lopez-Berestein8 shared
- Anil K Sood8 shared
- Lynne V Abruzzo5 shared
- Moran Amit5 shared
- Vittorio Cristini5 shared
- Bulent Ozpolat5 shared
- Florea Lupu3 shared
- Sai-Ching Jim Yeung3 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Anil K Sood$29,572,737
- Moran Amit$4,840,424
- Sai-Ching Jim Yeung$1,685,285
- Varsha Gandhi$2,500,715
- Scott Kopetz$13,199,822
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMicrornasGenesInnovationPlayCancer CellTissuesMalignant NeoplasmsCodeTumorProteinsBaseIn VivoCancer TherapyUntranslated RnaDeep SequencingSignal TransductionMouse ModelCalinBiologyNovel Therapeutic InterventionIn VitroSafetyCancer Patient
Grant awards (29)
Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer$678,424
R01 · FY2025 · DE
Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer$664,854
R01 · FY2024 · DE
Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer$130,434
R01 · FY2024 · DE
Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer$678,424
R01 · FY2023 · DE
Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer$673,034
R01 · FY2022 · DE
miR-155 targeted therapeutics for precision medicine in lung cancer$501,986
R01 · FY2022 · CA · contact PI
miR-155 targeted therapeutics for precision medicine in lung cancer$512,229
R01 · FY2021 · CA · contact PI
miR-155 targeted therapeutics for precision medicine in lung cancer$512,231
R01 · FY2020 · CA · contact PI
Viral miRs and cellular miRs in sepsis$354,598
R01 · FY2020 · GM · contact PI
Small molecule inhibitors of oncogenic miR-21$249,109
R41 · FY2020 · CA
miR-155 targeted therapeutics for precision medicine in lung cancer$502,255
R01 · FY2019 · CA · contact PI
Viral miRs and cellular miRs in sepsis$354,598
R01 · FY2019 · GM · contact PI
miR-155 targeted therapeutics for precision medicine in lung cancer$536,674
R01 · FY2018 · CA · contact PI
Protein-coding and non-coding RNA biomarkers for early detection of CLL$534,489
R01 · FY2018 · CA · contact PI
Viral miRs and cellular miRs in sepsis$369,598
R01 · FY2018 · GM · contact PI
Novel extra cellular RNA-based combinatorial RNA inhibition therapy$1,000,000
UH3 · FY2017 · TR
Protein-coding and non-coding RNA biomarkers for early detection of CLL$534,545
R01 · FY2017 · CA · contact PI
Novel extra cellular RNA-based combinatorial RNA inhibition therapy$1,000,000
UH3 · FY2016 · TR
Protein-coding and non-coding RNA biomarkers for early detection of CLL$574,442
R01 · FY2016 · CA · contact PI
Novel extra cellular RNA-based combinatorial RNA inhibition therapy$80,000
UH3 · FY2016 · TR
Novel extra cellular RNA-based combinatorial RNA inhibition therapy$999,500
UH3 · FY2015 · TR
Protein-coding and non-coding RNA biomarkers for early detection of CLL$677,471
R01 · FY2015 · CA · contact PI
Novel extra cellular RNA-based combinatorial RNA inhibition therapy$79,168
UH3 · FY2015 · TR
Protein-coding and non-coding RNA biomarkers for early detection of CLL$573,195
R01 · FY2014 · CA · contact PI
Novel extra cellular RNA-based combinatorial RNA inhibition therapy$500,000
UH2 · FY2014 · TR
HPV Communication to Microenvironment via Exosomes$80,000
UH2 · FY2014 · TR
Novel extra cellular RNA-based combinatorial RNA inhibition therapy$500,000
UH2 · FY2013 · TR
MicroRNAs and other non-coding RNAs in Colorectal Metastasis$315,833
R01 · FY2010 · CA · contact PI
MicroRNAs and other non-coding RNAs in Colorectal Metastasis$335,032
R01 · FY2009 · CA · contact PI